CCLA Investment Management Has $143.69 Million Stake in CME Group Inc. $CME

CCLA Investment Management decreased its holdings in CME Group Inc. (NASDAQ:CME) by 7.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 526,168 shares of the financial services provider’s stock after selling 40,035 shares during the quarter. CME Group accounts for about 2.3% of CCLA Investment Management’s portfolio, making the stock its 12th largest holding. CCLA Investment Management owned approximately 0.15% of CME Group worth $143,685,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Truist Financial Corp boosted its position in shares of CME Group by 8.9% in the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock valued at $19,106,000 after acquiring an additional 5,773 shares during the period. Alley Investment Management Company LLC boosted its position in shares of CME Group by 86.0% in the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock valued at $7,896,000 after acquiring an additional 13,512 shares during the period. Elevate Capital Advisors LLC boosted its position in shares of CME Group by 85.2% in the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after acquiring an additional 3,919 shares during the period. SG Americas Securities LLC boosted its position in shares of CME Group by 345.2% in the fourth quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock valued at $64,965,000 after acquiring an additional 184,459 shares during the period. Finally, Ashton Thomas Private Wealth LLC boosted its position in shares of CME Group by 78.8% in the third quarter. Ashton Thomas Private Wealth LLC now owns 13,281 shares of the financial services provider’s stock valued at $3,588,000 after acquiring an additional 5,855 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other news, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the sale, the general counsel owned 7,192 shares in the company, valued at approximately $2,397,597.04. The trade was a 31.39% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Dennis Suskind sold 748 shares of CME Group stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $300.00, for a total value of $224,400.00. Following the completion of the transaction, the director directly owned 2,699 shares of the company’s stock, valued at approximately $809,700. This represents a 21.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 8,539 shares of company stock worth $2,713,821. Corporate insiders own 0.30% of the company’s stock.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record trading volumes: CME reported Q1 international average daily volume (ADV) of a record 11.4M contracts (up 30% y/y), with all major product categories hitting highs — a direct revenue driver for the exchange. PR Newswire: Q1 2026 ADV
• Positive Sentiment: Crypto expansion: CME is launching Avalanche (AVAX) and Sui (SUI) futures on May 4 and pushing toward 24/7 crypto trading — moves that broaden product mix, attract institutional flow, and create new fee pools. Multiple outlets note this could reshape CME’s derivatives moat. Yahoo Finance: 24/7 Crypto Push
• Positive Sentiment: Near-term crypto momentum: Rising TVL for SUI and market rallies ahead of CME listings suggest initial demand for the new contracts, which could boost volumes at launch. Coingape: SUI TVL
• Positive Sentiment: Analyst support: Barclays raised its price target to $344 (equal weight) — signaling upside vs. the current quote — and some brokers express continuing earnings optimism. MarketScreener: Barclays PT
• Neutral Sentiment: New coverage: Keefe, Bruyette & Woods started coverage with “market perform” and a $305 target — a largely neutral signal that may cap near-term enthusiasm. Benzinga: KBW Coverage
• Neutral Sentiment: CME market data in focus: CME’s own feeds showed a shift in Fed-cut odds and are being used widely by markets — underscoring CME’s franchise but also tying sentiment to macro-driven volume swings. CNBC: Fed odds via CME
• Negative Sentiment: Near-term volatility and block trades: Large pre-news block trades in crude futures and a volatile market reaction to geopolitical developments increased intraday volatility — a factor that can prompt profit-taking and wider share swings even as volumes rise. QuiverQuant: Oil futures block sale

CME Group Stock Down 2.5%

Shares of NASDAQ CME opened at $302.81 on Thursday. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52 week low of $248.53 and a 52 week high of $329.16. The firm’s fifty day moving average is $306.06 and its 200 day moving average is $284.06. The company has a market cap of $108.59 billion, a price-to-earnings ratio of 27.13, a PEG ratio of 3.25 and a beta of 0.26.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the firm earned $2.52 earnings per share. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. On average, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th were issued a dividend of $1.30 per share. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date was Tuesday, March 10th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. CME Group’s dividend payout ratio (DPR) is presently 46.59%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CME shares. The Goldman Sachs Group raised their target price on shares of CME Group from $266.00 to $275.00 and gave the company a “sell” rating in a research note on Monday, March 16th. Keefe, Bruyette & Woods started coverage on shares of CME Group in a research note on Wednesday. They issued a “market perform” rating and a $305.00 target price on the stock. Jefferies Financial Group raised their target price on shares of CME Group from $302.00 to $356.00 and gave the company a “buy” rating in a research note on Monday, March 2nd. UBS Group reaffirmed a “neutral” rating and issued a $310.00 target price on shares of CME Group in a research note on Friday, February 6th. Finally, Royal Bank Of Canada raised their target price on shares of CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research note on Thursday, February 5th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, CME Group presently has a consensus rating of “Moderate Buy” and an average price target of $307.59.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.